Chalkis Health Industry Co., Ltd. Class A

Chalkis Health Industry Co., Ltd. Class A

SSZSE:000972
4.06
CNY
+0.37
(+10.03%)
2.41BMarket Cap
Chalkis Health Industry Co., Ltd. Class A
SZSE:000972
(Shenzhen Stock Exchange)

Recent

price

4.06

P/E

ratio

- -

div

yld

0.22%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
2.06
2.96
1.56
1.24
0.54
0.88
0.72
0.58
0.81
0.43
0.03
0.23
0.68
0.75
0.4
0.64
- -
Revenue per Share
-0.43
-2.39
0.08
-0.47
0.01
-0.06
-0.33
0.03
-0.55
0.01
-0.34
-0.14
0.03
0.14
-0.3
-0.06
- -
Basic EPS, GAAP
-0.79
-2.06
-0.05
0.44
-0.25
-0.44
-0.27
-0.22
0.53
0.29
-0.02
-0.26
0.21
-0.51
-0.17
0.25
- -
Free Cash Flow per Basic Share
0.24
0.34
0.13
0.07
0.05
0.04
0.03
0.04
0.04
0.02
- -
0.01
0.01
0.02
0.03
0.03
0.01
Dividend per Share
1.79
0.27
0.54
0.21
1.05
1.41
1.09
1.14
0.57
0.57
0.23
0.09
0.12
0.26
-0.04
0.03
-0.05
Book Value per Share
1.49
0.11
0.38
0.07
1.04
1.28
0.96
1.02
0.46
0.57
0.23
0.09
0.12
0.24
-0.06
0.01
-0.07
Tangible Book Value per Share
735
482
800
771
772
772
834
886
771
498
782
763
870
771
771
772
771
Basic Weighted Avg Shares
1,512
1,425
1,246
955
417
683
599
518
627
213
23
174
589
576
308
492
- -
Sales/Revenue/Turnover
-30.52
-16.54
-9.05
-22.47
-11.2
-12.85
-24.1
-11.84
-47.3
-26.21
-230.89
-18.91
20.1
13.98
-13.19
29.92
- -
Operating Margin (%)
186
187
179
173
97
100
25
106
91
53
47
46
45
41
37
38
- -
Depreciation Expense
-312
-1,152
64
-366
11
-48
-275
27
-424
5
-266
-107
26
108
-231
-46
- -
Net Income, GAAP
- -
- -
92.05
- -
0.59
- -
- -
8.09
- -
22.32
- -
- -
16.86
0.2
- -
- -
- -
Effective Tax Rate (%)
-20.65
-80.83
5.14
-38.29
2.7
-7.07
-45.91
5.13
-67.64
2.33
-1,157.76
-61.23
4.43
18.8
-74.89
-9.39
- -
Profit Margin (%)
-125
-1,485
-1,710
-1,707
-215
-252
-365
-173
-151
48
-24
-110
-61
-143
-303
-249
-312
Working Capital
810
417
50
133
62
- -
- -
- -
- -
- -
20
- -
- -
73
75
57
53
LT Debt
1,406
72
218
-164
768
1,030
766
881
443
448
181
74
100
209
-17
27
-41
Total Equity
- -
- -
-2.97
- -
-32.77
- -
- -
-11.57
- -
2.57
- -
- -
- -
39.63
- -
- -
- -
Return on Invested Capital (%)
- -
- -
8.23
- -
-5.99
- -
- -
-0.49
- -
2.6
- -
- -
38.23
34.48
- -
- -
- -
Return on Capital (%)
-24.72
-145.03
20.54
-127.46
2.32
-5.08
-28.58
3.1
-64.39
1.13
-86.05
-87.1
31.71
72.43
- -
- -
- -
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
620
607
501
LT Borrowings
57
57
53
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
771
771
771
Market Capitalization
3,023
3,023
2,414

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
769
709
553
Cash, Cash Equivalents & STI
313
282
301
Accounts Receivable, Net
50
48
42
Inventories
345
294
118
Total Current Liabilities
1,018
979
864
Payables & Accruals
- -
- -
- -
ST Debt
620
607
501
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-40.05%
-56.34%
-258.26%
Free Cash Flow
0.48%
108.29%
-242.33%
Net Income, GAAP
-714.21%
-52.5%
-79.97%
Sales/Revenue/Turnover
74.83%
181.67%
59.7%
Total Cash Common Dividend
165.79%
364.23%
-13.9%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
119
126
53
10
308
2025
79
166
- -
138
492
2026
55
142
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
-0.07
-0.24
-0.3
2025
-0.01
-0.09
- -
0.13
-0.06
2026
-0.03
-0.06
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
0.01
0.01
0.01
0.03
2025
0.01
0.01
- -
- -
0.03
2026
- -
0.01
- -
- -
- -
Business
Chalkis Health Industry Co., Ltd. is a major player in the agricultural sector, specializing in the cultivation, processing, and global distribution of a diverse array of tomato and fruit products. The company offers concentrated tomato paste in various formats, including aseptic drums and tinned varieties, alongside items such as peeled and diced tomatoes, an assortment of canned tomato goods, and specialized products like tomato fiber sheets and tomato seed oil. They also produce lycopene capsules, aligning with their focus on health-related agricultural derivatives. Operating as a leading enterprise in agricultural industrialization, Chalkis Health Industry leverages its extensive manufacturing capabilities for both domestic and international markets. The entity, previously known as Xinjiang Chalkis Co., Ltd., adopted its current name in May 2016. Headquartered in Wujiaqu, Xinjiang, China, the company continues to develop its robust product portfolio.